연구성과로 돌아가기
2024 연구자 정보 (190 / 1079)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Bouattour, M. (Bouattour, M) |
Hop Beaujon, AP HP, Med Oncol, Paris, France |
|
|
[JCR상위 6.4] mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible Hepatocellular Carcinoma | SCIE | 6.4 | ONCOLOGY;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | |||
|
Catanzaro, Jason (Catanzaro, J) |
Yale Univ, Sch Med, Dept Pediat, Sect Pulm Allergy Immunol & Sleep Med, New Haven, CT 06520 USA |
|
|
[JCR상위 6.4] IL-1 receptor 1 signaling shapes the development of viral antigen-specific fi c CD4+ | SCIE | 6.4 | MEDICINE, RESEARCH & EXPERIMENTAL | insoo.kang@yale.edu; | ||
|
Chan, S. (Chan, S) |
Chinese Univ Hong Kong, Dept Clin Oncol, State Key Lab Translat Oncol, Sir Yue Kong Pao Ctr Canc, Hong Kong, Peoples R China |
|
|
[JCR상위 6.4] mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible Hepatocellular Carcinoma | SCIE | 6.4 | ONCOLOGY;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | |||
|
Cho, Yeoungjee (Cho, YJ) |
Princess Alexandra Hosp, Dept Kidney & Transplant Serv, Brisbane, Qld, Australia Univ Queensland, Ctr Hlth Serv Res, Australasian Kidney Trials Network, Brisbane, Qld, Australia |
G-6176-2013 Cho, Yeoungjee |
0000-0002-3502-9837 Cho, Yeoungjee |
[JCR상위 6.4] Prevalence and Outcomes of Chronic Kidney Disease-Associated Pruritus | SCIE | 6.4 | UROLOGY & NEPHROLOGY | KarthikK.Tennankore@nshealth.ca; | ||
|
Choi, Byeong Jo (Choi, BJ) |
Korea Res Inst Biosci & Biotechnol KRIBB, Lab Anim Resource & Res Ctr, Cheongju 28116, South Korea |
|
|
[JCR상위 6.4] Homology-independent targeted insertion-mediated derivation of M1-biased macrophages harbouring Megf10 and CD31; 1; from human pluripotent stem cells | SCIE | 6.4 | MEDICINE, RESEARCH & EXPERIMENTAL | jonglee@kribb.re.kr;zhenxing93@kribb.re.kr;jieun622@kribb.re.kr;byung127@kribb.re.kr;kanjon@kribb.re.kr;brightnessd@kribb.re.kr;shhong@kangwon.ac.kr;lee1@knu.ac.kr; | ||
|
Chuken, Y. A. Lopez (Chuken, YAL) |
I Can Oncol Ctr, New Leon, Mexico |
|
|
[JCR상위 6.4] mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible Hepatocellular Carcinoma | SCIE | 6.4 | ONCOLOGY;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | |||
|
Cohen, G. J. (Cohen, GJ) |
AstraZeneca, Global Med Dev, Gaithersburg, MD USA |
|
|
[JCR상위 6.4] mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible Hepatocellular Carcinoma | SCIE | 6.4 | ONCOLOGY;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | |||
|
Erinjeri, J. P. (Erinjeri, JP) |
Mem Sloan Kettering Canc Ctr, lntervent Radiol Serv, New York, NY USA |
|
|
[JCR상위 6.4] mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible Hepatocellular Carcinoma | SCIE | 6.4 | ONCOLOGY;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | |||
|
Heo, J. (Heo, J) |
Pusan Natl Univ, Dept Internal Med, Coll Med, Busan, South Korea Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea Univ Seoul, Seoul, South Korea |
MHQ-1390-2025 Heo, Jeong |
0000-0003-4463-4104 Heo, Jeewon |
[JCR상위 6.4] mRECIST Outcomes in EMERALD-1: A Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization plus Durvalumab with or without Bevacizumab in Participants with Embolization-Eligible Hepatocellular Carcinoma [JCR상위 24.2] Measurement of the background in the CMS muon detector in pp-collisions at √s=13 TeV |
SCIE | 6.4 |
ONCOLOGY;RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING PHYSICS, PARTICLES & FIELDS |
piet.verwilligen@cern.ch; | ||
|
Hong, Seok-Ho (Hong, SH) |
Kangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon 24341, South Korea KW Bio Co Ltd, Chunchon 24252, South Korea |
|
|
[JCR상위 6.4] Homology-independent targeted insertion-mediated derivation of M1-biased macrophages harbouring Megf10 and CD31; 1; from human pluripotent stem cells | SCIE | 6.4 | MEDICINE, RESEARCH & EXPERIMENTAL | jonglee@kribb.re.kr;zhenxing93@kribb.re.kr;jieun622@kribb.re.kr;byung127@kribb.re.kr;kanjon@kribb.re.kr;brightnessd@kribb.re.kr;shhong@kangwon.ac.kr;lee1@knu.ac.kr; | ||
|
Jeon, Sangchoon (Jeon, S) |
Yale Univ, Sch Nursing, West Haven, CT 06516 USA |
E-3800-2013 Jeon, Sangchoon |
|
[JCR상위 6.4] IL-1 receptor 1 signaling shapes the development of viral antigen-specific fi c CD4+ | SCIE | 6.4 | MEDICINE, RESEARCH & EXPERIMENTAL | insoo.kang@yale.edu; | ||
|
Kang, Byunghyun (Kang, B) |
NIH, NIAID, Mucosal Immunol Sect, Lab Mol Immunol, Bethesda, MD 20892 USA |
|
|
[JCR상위 6.4] IL-1 receptor 1 signaling shapes the development of viral antigen-specific fi c CD4+ | SCIE | 6.4 | MEDICINE, RESEARCH & EXPERIMENTAL | insoo.kang@yale.edu; | ||
|
Kang, Jong Soon (Kang, JS) |
Korea Res Inst Biosci & Biotechnol KRIBB, Lab Anim Resource & Res Ctr, Cheongju 28116, South Korea |
|
|
[JCR상위 6.4] Homology-independent targeted insertion-mediated derivation of M1-biased macrophages harbouring Megf10 and CD31; 1; from human pluripotent stem cells | SCIE | 6.4 | MEDICINE, RESEARCH & EXPERIMENTAL | jonglee@kribb.re.kr;zhenxing93@kribb.re.kr;jieun622@kribb.re.kr;byung127@kribb.re.kr;kanjon@kribb.re.kr;brightnessd@kribb.re.kr;shhong@kangwon.ac.kr;lee1@knu.ac.kr; | ||
|
Kanjanabuch, Talerngsak (Kanjanabuch, T) |
Chulalongkorn Univ, Fac Med, Dept Med, Div Nephrol, Bangkok, Thailand Chulalongkorn Univ, Fac Med, Ctr Excellence Kidney Metab Disorders, Bangkok, Thailand Chulalongkorn Univ, Fac Med, Sch Global Hlth, Div Nephrol,Dept Med, Bangkok, Thailand Chulalongkorn Univ, Fac Med, Ctr Excellence Kidney Metab Disorders, Sch Global Hlth, Bangkok, Thailand Chulalongkorn Univ, Fac Med, Sch Global Hlth, Dialysis Policy & Practice Program DiP3, Bangkok, Thailand |
|
|
[JCR상위 6.4] Prevalence and Outcomes of Chronic Kidney Disease-Associated Pruritus [JCR상위 16.2] International variations in serum PTH and calcium levels and their mortality associations in peritoneal dialysis patients: Results from PDOPPS |
SCIE | 6.4 | UROLOGY & NEPHROLOGY |
KarthikK.Tennankore@nshealth.ca; Brian.Bieber@ArborResearch.org; |
||
|
Karuppiah, Chelladurai (Karuppiah, C) |
교신저자 |
Kyungpook Natl Univ, Dept Chem & Green Nano Mat, Res Ctr, 80 Daehakro, Daegu City 41566, South Korea Kyungpook Natl Univ, Dept Chem, Daegu 41566, South Korea Kyungpook Natl Univ, Green Nano Mat Res Ctr, Daegu 41566, South Korea Ming Chi Univ Technol, Battery Res Ctr Green Energy, New Taipei City 24301, Taiwan Kyungpook Natl Univ, Dept Chem, 80 Daehakro, Daegu 41566, South Korea Kyungpook Natl Univ, Green Nano Mat Res Ctr, 80 Daehakro, Daegu 41566, South Korea Kyungpook Natl Univ, Dept Chem & Greennano Mat, Res Ctr, 80 Daehakro, Daegu 41566, South Korea |
H-7068-2019 Karuppiah, Chelladurai |
0000-0003-0811-2376 Karuppiah, Chelladurai |
[JCR상위 6.4] Voltammetric Aptamer-Based Biochip Featuring Poly Gallic Acid/SnO2-MoO3 Nanocomposite for Selective Tryptophan Detection: Potential Application in Alzheimer's Diagnosis [JCR상위 23.7] In Situ Interphase Engineering for beyond Lithium-Ion Battery Technologies [JCR상위 14.0] Synergistic control of cohesive and adhesive forces in anchored porous CoMn 2 O 4 for superior reversible lithium-ion storage and high energy-power density [JCR상위 5.1] Review on dendrite formation of Mg metal anode and its prevention [JCR상위 4.2] Highly sensitive detection of environmental toxic fenitrothion in fruits and water using a porous graphene oxide nanosheets based disposable sensor [JCR상위 18.5] Rapid detection of tertiary butylated hydroquinone in food samples using Mn-MOF@f-CNF composite-modified screen-printed electrode |
SCIE | 4.2 |
BIOCHEMICAL RESEARCH METHODS;CHEMISTRY, ANALYTICAL;NANOSCIENCE & NANOTECHNOLOGY ENERGY & FUELS;ENGINEERING, CHEMICAL ENERGY & FUELS CHEMISTRY, PHYSICAL;MATERIALS SCIENCE, MULTIDISCIPLINARY;NANOSCIENCE & NANOTECHNOLOGY;PHYSICS, APPLIED ENVIRONMENTAL SCIENCES;PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH CHEMISTRY, ANALYTICAL |
kcdurai.rmd@gmail.com;hyejinlee@knu.ac.kr; jkling@mail.mcut.edu.tw;hyejinlee@knu.ac.kr;ccyang@mail.mcut.edu.tw;rjose@umpsa.edu.my; apsakthivel@yahoo.com;ccyang@mail.mcut.edu.tw; kotobuki@mail.mcut.edu.tw;luli@nus.edu.sg; kcdurai.rmd@gmail.com;hyejinlee@knu.ac.kr;sayeekannanramaraj@gmail.com; mgsethu@gmail.com;tyliu@mail.mcut.edu.tw; |
페이지 이동: